文献速递前列腺增生与排尿功能障碍

背侧颊黏膜补片尿道成形术治疗女性尿道狭窄:单术者200余例结局

Dorsal Onlay Labial Mucosal Graft Urethroplasty in Female Urethral Stricture: Outcomes of Over 200 Cases From a Single Surgeon.
PubMed 文献 · Urology · 2025-05-23

本研究回顾性分析204例接受背侧颊黏膜补片尿道成形术的女性尿道狭窄患者,中位随访29个月。1-3个月、6个月和2年临床成功率分别为98.5%、97.5%和93.5%,2年复发率6.5%,围手术期并发症少,症状改善率高,提示该术式安全有效且疗效持久。

要点

  • 背侧颊黏膜补片尿道成形术治疗女性尿道狭窄2年临床成功率达93.5%。
  • 2年复发率6.5%,仅4例需再次尿道成形术。
  • 围手术期Clavien-Dindo 2-3级并发症仅6例(2.94%),无显著供区并发症。

核心结论

  • 背侧颊黏膜补片尿道成形术是女性尿道狭窄安全有效的治疗方式,成功率高、并发症少且疗效持久。

研究设计与样本

  • 回顾性分析前瞻性维护数据库,纳入2013年6月至2024年7月间204例因女性尿道狭窄接受背侧颊黏膜补片尿道成形术的患者。

主要发现

  • 平均手术时间97.7±13分钟,中位住院2天(范围2-11天)。
  • 围手术期Clavien-Dindo 2-3级并发症6例(2.94%),无显著供区并发症。
  • 中位随访29个月(范围7-131个月),1-3个月、6个月和2年临床成功率分别为98.5%、97.5%和93.5%。
  • 2年复发率6.5%,其中4例需再次尿道成形术。
  • 1-3个月和2年分别有95%和88.1%的患者报告症状改善。

临床怎么用

  • 对于症状性女性尿道狭窄经尿流率、排尿性膀胱尿道造影或尿道校准确诊者,可考虑背侧颊黏膜补片尿道成形术。

局限性

  • 本研究为单术者回顾性分析,证据等级受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the outcomes of dorsal onlay labial mucosal graft urethroplasty in female urethral stricture (FUS), a condition that remains challenging and frequently underdiagnosed due to nonspecific symptoms and diagnostic limitations. METHODS: A retrospective analysis of a prospectively maintained database was conducted, including 204 patients who underwent dorsal onlay labial mucosal graft urethroplasty for FUS between June 2013 and July 2024. Patients were included if they had symptomatic FUS confirmed by uroflowmetry, micturating cystourethrogram, or urethral calibration. Outcomes assessed included clinical success rates, recurrence, complications, and subjective improvement based on the Global Impression of Improvement (GII). RESULTS: The mean operative time was 97.7 ± 13 minutes, with a median hospital stay of 2 days (range: 2-11). Perioperative complications were minimal, with six cases (2.94%) of Clavien-Dindo grade 2-3 complications and no significant donor-site morbidity. At a median follow-up of 29 months (range: 7-131), clinical success rates were 98.5%, 97.5%, and 93.5% at 1-3 months, 6 months, and 2 years, respectively. Recurrence was observed in 6.5% of patients at 2 years, with 4 requiring repeat urethroplasty. Symptom improvement was reported by 95% of patients at 1-3 months and 88.1% at 2 years. CONCLUSION: Dorsal onlay labial mucosal graft urethroplasty is a safe and effective treatment for FUS, with high success rates, minimal complications, and durable outcomes. This study, the largest single-surgeon series, highlights the utility of this approach as a reliable option for managing this underdiagnosed condition.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Jena AK, Jena R, Madhavan M, et al. Dorsal Onlay Labial Mucosal Graft Urethroplasty in Female Urethral Stricture: Outcomes of Over 200 Cases From a Single Surgeon. Urology. 2025. PMID: 40414431. doi:10.1016/j.urology.2025.05.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。